This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wen, C.-C. Articles by Wang, W.-B. Search for Related Content PubMed PubMed Citation Articles by Wen, C.-C. Articles by Wang, W.-B.

SV40 T/t-Common Polypeptide Specifically Induces Apoptosis in Human Cancer Cells that Overexpress HER2/neu

Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan

Requests for reprints: Won-Bo Wang, Graduate Institute of Microbiology, College of Medicine, National Taiwan University, No. 1, Jen Ai Road, 1st Section, Taipei, Taiwan. Phone: 886-2-2312-3456 ext. 8285; Fax: 886-2-2391-5293; E-mail: wbwang{at}ha.mc.ntu.edu.tw.

Previously, we reported that SV40 T/t-common polypeptide, which contains the NH₂-terminal common domain of SV40 large T and small t antigens, can repress HER2/neu (also known as erbB-2) expression and consequently suppress the tumorigenic potential of the HER2/neu-overexpressing ovarian carcinoma cells. Here we report that T/t-common could specifically induce apoptosis in HER2/neu-overexpressing human cancer cell lines but not in nontransformed cell lines and HER2/neu low-expressing human cancer cell lines. The ability of T/t-common to induce apoptosis in HER2/neu-overexpressing cancer cells was derived from its ability to inhibit HER2/neu because reexpression of a large amount of HER2/neu could block apoptosis induced by T/t-common. T/t-common expression in HER2/neu-overexpressing SK-OV-3 cancer cells led to down-regulation of Bcl-2 and Bcl-X_L, and overexpression of Bcl-2 could inhibit the ability of T/t-common to induce apoptosis in these cells. Therefore, the apoptosis-inducing activity of T/t-common is related to its ability to inhibit Bcl-2 expression in HER2/neu-overexpressing cancer cells. Consistent with the apoptosis-inducing activity of T/t-common, we found that T/t-common could specifically inhibit the soft-agarose colony-forming ability of the HER2/neu-overexpressing human cancer cell lines but not that of the HER2/neu low-expressing human cancer cell lines. Finally, we showed that T/t-common could specifically sensitize HER2/neu-overexpressing human cancer cell lines, but not HER2/neu low-expressing human cancer cell lines, to chemotherapeutic agent etoposide. Together, these data suggest that T/t-common alone or in combination with chemotherapy may provide a new approach for treatment of cancers that overexpress HER2/neu. (Cancer Res 2006; 66(11): 5847-57)

This article has been cited by other articles:

				S.-H. Pan, C.-C. Tai, C.-S. Lin, W.-B. Hsu, S.-F. Chou, C.-C. Lai, J.-Y. Chen, H.-F. Tien, F.-Y. Lee, and W.-B. Wang Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability Carcinogenesis, February 1, 2009; 30(2): 366 - 375. [Abstract] [Full Text] [PDF]